MIT researchers engineered a new synthetic peptide called clavanin-MO, which exhibits potent antimicrobial and immunomodulatory properties both in vitro and in vivo in animal models that effectively killed a panel of representative bacterial strains, including multidrug-resistant hospital isolates.

See the source article by following the link below:
MIT researchers engineered a new synthetic peptide called clavanin-MO, which exhibits potent antimicrobial and immunomodulatory properties both in vitro and in vivo in animal models that effectively killed a panel of representative bacterial strains, including multidrug-resistant hospital isolates.